Skip to main content

Table 1 General Characteristics

From: Tricuspid annular plane systolic excursion and central venous pressure in mechanically ventilated critically ill patients

Categories

LVEF<55%(n = 31)

LVEF≥55%(n = 43)

p

Age (yr)

67.4 ± 16.5

61.1 ± 15.5

0.096

Sex (male, %)

23 (71.9%)

26 (60.5%)

0.303

APACHEII

20.6 ± 8.1

16.9 ± 6.2

0.032

SOFA

9.5 ± 2.6

7.4 ± 3.0

0.005

Reason for admission (n, %)

 Sepsis

18 (56.3%)

22(51.2%)

0.674

 High-risk Surgery

10 (31.3%)

19(44.2%)

0.250

 Others

4 (12.5%)

2 (4.7%)

0.220

Comorbidities (n, %)

 HTN

13 (40.6%)

14 (32.6%)

0.466

 CAD

4 (12.5%)

4 (9.3%)

0.650

 DM

6 (18.7%)

7 (16.3%)

0.762

 Stroke

2 (6.3%)

1 (2.3%)

0.405

NE (n, %)

23 (71.9%)

20 (46.5%)

0.027

NE dose (μg/kg/min)

0.35 (0.19, 0.60)

0.18 (0.06, 0.30)

0.008

ARDS (n, %)

7 (22.6%)

5 (11.6%)

0.201

PEEP (mmHg)

6.1 ± 1.9

5.7 ± 1.4

0.310

Pplat (mmHg)

16.1 ± 4.7

15.9 ± 2.9

0.798

  1. *Others: stroke, renal failure, severe electrolyte disturbances
  2. APACHE acute physiology and chronic health evaluation, SOFA sequential organ failure assessment, HTN hypertension, CAD coronary arterial disease, DM diabetes mellitus, NE norepinephrine, ARDS acute respiratory distress syndrome, PEEP positive end expiratory pressure, Pplat plateau pressure